ATE114468T1 - Ethyl-(+)-apovincaminat zur behandlung der demyelinisierung klinischer erscheinungen autoimmunen ursprungs. - Google Patents

Ethyl-(+)-apovincaminat zur behandlung der demyelinisierung klinischer erscheinungen autoimmunen ursprungs.

Info

Publication number
ATE114468T1
ATE114468T1 AT88307883T AT88307883T ATE114468T1 AT E114468 T1 ATE114468 T1 AT E114468T1 AT 88307883 T AT88307883 T AT 88307883T AT 88307883 T AT88307883 T AT 88307883T AT E114468 T1 ATE114468 T1 AT E114468T1
Authority
AT
Austria
Prior art keywords
demyelinization
treatment
apovincaminate
ethyl
autoimmune origin
Prior art date
Application number
AT88307883T
Other languages
English (en)
Inventor
Gabor Tigyi
Zsuzsa Szegvari
Gryorgy Hajos
Bela Bozoky
Tibor Frank
Laszlo Szporny
Lilla Forgacs
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Application granted granted Critical
Publication of ATE114468T1 publication Critical patent/ATE114468T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
AT88307883T 1987-08-26 1988-08-25 Ethyl-(+)-apovincaminat zur behandlung der demyelinisierung klinischer erscheinungen autoimmunen ursprungs. ATE114468T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU873753A HU201674B (en) 1987-08-26 1987-08-26 Process for producing pharmaceutical composition suitable for curing autoimmune-type leukoencephalomyelitic diseases e.g. sclerosis multiplex

Publications (1)

Publication Number Publication Date
ATE114468T1 true ATE114468T1 (de) 1994-12-15

Family

ID=10965341

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88307883T ATE114468T1 (de) 1987-08-26 1988-08-25 Ethyl-(+)-apovincaminat zur behandlung der demyelinisierung klinischer erscheinungen autoimmunen ursprungs.

Country Status (6)

Country Link
US (1) US4882336A (de)
EP (1) EP0305181B1 (de)
JP (1) JP2655694B2 (de)
AT (1) ATE114468T1 (de)
DE (1) DE3852246D1 (de)
HU (1) HU201674B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4632996A (en) * 1995-02-15 1996-09-04 Takeda Chemical Industries Ltd. Use of vinpocetine derivatives for inhibiting production or secretion of amyloid beta protein
US6127387A (en) * 1996-12-10 2000-10-03 Thomas Jefferson University Use of CD4-binding small molecules to inhibit immune responses
MXPA05013857A (es) * 2003-06-25 2006-05-17 Charles Erwin Combinacion quimica y metodo para aumentar la liberacion de coenzima q10.
WO2005039482A2 (es) * 2003-10-28 2005-05-06 Universidad Nacional Autónoma de México Uso de la vinpocetina para prevenir las complicaciones, particularmente las relacionadas con la audición, que acompañan a la epilepsia y su tratamiento
RU2262931C2 (ru) * 2003-11-03 2005-10-27 Закрытое Акционерное Общество "Канонфарма Продакшн" Фармацевтическая композиция, обладающая церебровазодилатирующей и ноотропной активностью
US20100221340A1 (en) 2007-09-20 2010-09-02 University Of Rochester Method and compositions for treatment or prevention of inflammatory conditions
WO2011143442A1 (en) * 2010-05-12 2011-11-17 Trovis Pharmaceuticals, Llc. A method of treating multiple sclerosis with adenosine receptor agonists
US11058637B1 (en) * 2020-11-25 2021-07-13 King Abdulaziz University Surface-modified emulsomes for intranasal delivery of drugs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU532001B2 (en) * 1978-11-20 1983-09-15 Sumitomo Chemical Company, Limited Polycyclic indole derivatives

Also Published As

Publication number Publication date
EP0305181B1 (de) 1994-11-30
DE3852246D1 (de) 1995-01-12
EP0305181A3 (en) 1990-08-22
EP0305181A2 (de) 1989-03-01
HU201674B (en) 1990-12-28
JP2655694B2 (ja) 1997-09-24
HUT52698A (en) 1990-08-28
US4882336A (en) 1989-11-21
JPS6471814A (en) 1989-03-16

Similar Documents

Publication Publication Date Title
DE3772429D1 (de) Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten.
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
DE3852959D1 (de) Verfahren zur Herstellung von N-substituiertes Amin.
DE3878627T2 (de) Zusammensetzung zur oberflaechenbehandlung von kautschuk.
DE3882775D1 (de) Zusammensetzung zur behandlung von parodontaler krankheit.
DE69022269D1 (de) Verfahren zur thermischen Behandlung von Silizium.
DE3869590D1 (de) Mischung zur behandlung von hypercholesterolemie.
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ATE114468T1 (de) Ethyl-(+)-apovincaminat zur behandlung der demyelinisierung klinischer erscheinungen autoimmunen ursprungs.
DE58906613D1 (de) Verfahren zur Herstellung von orthodontischen Teilen.
DE3855580D1 (de) Verfahren zur Herstellung von Polyparaphenylensulfiden
DE3786411T2 (de) Verfahren zur Herstellung von gehärteten Siloxanzusammensetzungen.
DE336374T1 (de) Behandlung von zusammensetzungen von polyimid-vorlaeufern.
DE3761377D1 (de) Verfahren zur aufarbeitung von 2-merkaptobenzthiazol enthaltenden teeren.
DE3853926T2 (de) 2-Oxa-isocephem-Verbindungen, diese enthaltende Zusammensetzungen und Verfahren zur Herstellung dieser Verbindungen.
DE68923836D1 (de) Verfahren zur Herstellung von wässrigen Zusammensetzungen von Silikonelastomeren.
DE3865484D1 (de) Verfahren zur herstellung von urantetrafluorid und von schwefelfluoriden mittels redoktion von uranhexafluorid.
DE69011065T2 (de) Verfahren zur Behandlung von Nickel-Magnesium-Silikaterzen.
DE68918449D1 (de) Siliziumverbindungen zur behandlung von knochen.
DE69022027T2 (de) 2-Alkyl-3-benzoylbenzofurane zur Behandlung von Herzarrhythmia.
ATE74004T1 (de) Mischung zur behandlung von hypercholesterolemie.
ATE76571T1 (de) Zusammensetzung zur behandlung der haut.
AT400300B (de) Therapeutische zusammensetzungen enthaltend teilweise neue oktahydroindenofuranderivate, verfahren zur herstellung dieser verbindungen und neue oktahydroindenofuranderivate
ATE51004T1 (de) Verfahren zur herstellung von 9(11)dehydroandrostanen.
ATE64683T1 (de) Zusammensetzung zur behandlung von haemorroiden.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties